Genous Bio-engineered R stent: Post-marketing study data

In a post-marketing study of Genous in 236 patients with predominantly complex lesions, the TLR rate was 8% and the MACE rate was 14% at 1 year. One patient experienced acute stent thrombosis at 24 ho...